Dr. Robert A. Zlotecki, MD

Dr. Zlotecki practices at Musc Tidelands Health Radiation Therapy Center - HOPD in Murrells Inlet, South Carolina.

Dr. Zlotecki's NPI, 1821059338, was assigned on April 1, 2006. Dr. Zlotecki graduated from University Of Michigan Medical School in 1988. Dr. Zlotecki holds Florida license ME64389.

Dr. Zlotecki's primary practice is Musc Tidelands Health Radiation Therapy Center - HOPD, at 4033 Highway 17, Murrells Inlet, SC 29576.

Dr. Zlotecki's primary practice is Musc Tidelands Health Radiation Therapy Center - HOPD in Murrells Inlet, South Carolina. Dr. Zlotecki is also affiliated with Tidelands Waccamaw Community Hospital. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Zlotecki to 2 more hospitals, each named with a free account. Dr. Zlotecki's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zlotecki practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Zlotecki's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Zlotecki is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Zlotecki's licenses on file in 3 states: Florida, South Carolina and Michigan.

Dmand AI lists bladder cancer radiation, bone cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, lung cancer radiation, pancreatic cancer radiation and prostate cancer radiation among the conditions Dr. Zlotecki treats.

CMS data shows 5,502 Medicare services from Dr. Zlotecki across 25 procedure codes in 2024, for 220 Medicare patients. Medicare paid $597,972 for them. Every service was in an office.

CMS counts 220 Medicare patients who saw Dr. Zlotecki in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zlotecki's median patient age at 72, with 42% women.

In 2024, Dr. Zlotecki wrote 141 Medicare Part D claims for 55 patients. 87% of them were for generic drugs. CMS names the drug for 92 of them, across 5 drugs with 11 or more claims each, at $39,926 in total drug cost. In 2023, CMS named 171 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Zlotecki for performance year 2024, reported through an alternative payment model (APM). Dr. Zlotecki accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 78 papers to Dr. Zlotecki, published from 2008 to 2023. 2012 was the busiest year, with 3. The most frequent topics are Radiotherapy, Adjuvant, Radiotherapy Dosage and Adenocarcinoma. Dr. Zlotecki has published most often in Am J Clin Oncol. Dr. Zlotecki's most frequent co-authors are Mark T. Scarborough, MD, William M. Mendenhall, MD and Daniel J. Indelicato, MD.

CMS Open Payments shows 31 general payments to Dr. Zlotecki from 4 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 90% of the total. Elekta, Inc. paid the most, $6,931.

Dr. Zlotecki graduated from University Of Michigan Medical School in 1988.

Dr. Zlotecki is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.